Ling Deng

发表

Chromatin complexes subunit BAP18 promotes triple-negative breast cancer progression through transcriptional activation of oncogene S100A9

Da-Qiang Li, Fang-Lin Zhang, Y. Ning, 2022, Cell death & disease.

RNF144A exerts tumor suppressor function in breast cancer through targeting YY1 for proteasomal degradation to downregulate GMFG expression

Da-Qiang Li, Fang-Lin Zhang, Y. Ning, 2022, Medical Oncology.

TOLLIP-mediated autophagic degradation pathway links the VCP-TMEM63A-DERL1 signaling axis to triple-negative breast cancer progression

Da-Qiang Li, Z. Shao, Fan Yang, 2022, Autophagy.

SH3BGRL2 exerts a dual function in breast cancer growth and metastasis and is regulated by TGF-β1.

Da-Qiang Li, Fang-Lin Zhang, Ling Deng, 2020, American journal of cancer research.

Protein Phosphatase 1 Subunit PPP1R14B Stabilizes STMN1 to Promote Progression and Paclitaxel Resistance in Triple-Negative Breast Cancer

Z. Shao, Da-Qiang Li, Fang-Lin Zhang, 2022, Cancer research.

MYC-driven U2SURP regulates alternative splicing of SAT1 to promote triple-negative breast cancer progression.

Da-Qiang Li, Fang-Lin Zhang, Yin-Ling Zhang, 2023, Cancer letters.

Destabilization of microrchidia family CW‐type zinc finger 2 via the cyclin‐dependent kinase 1‐chaperone‐mediated autophagy pathway promotes mitotic arrest and enhances cancer cellular sensitivity to microtubule‐targeting agents

Da-Qiang Li, Z. Shao, Fang-Lin Zhang, 2023, Clinical and translational medicine.

Inositol monophosphatase 1 (IMPA1) promotes triple‐negative breast cancer progression through regulating mTOR pathway and EMT process

Da-Qiang Li, Fang-Lin Zhang, Yin-Ling Zhang, 2022, Cancer medicine.

SIRTUIN 1 MEDIATED PHOTOBIOMODULATION

Ling Deng, T. Liu, 2012 .

Dynamic SUMOylation of MORC2 orchestrates chromatin remodelling and DNA repair in response to DNA damage and drives chemoresistance in breast cancer

Da-Qiang Li, Fang-Lin Zhang, Z. Shao, 2023, Theranostics.

C9orf142 transcriptionally activates MTBP to drive progression and resistance to CDK4/6 inhibitor in triple‐negative breast cancer

Da-Qiang Li, Fang-Lin Zhang, Yin-Ling Zhang, 2023, Clinical and translational medicine.